Application 202666

Type
ANDA
Sponsor
TWI PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEXLANSOPRAZOLEDEXLANSOPRAZOLECAPSULE, DELAYED RELEASE;ORAL30MGNoNo
002DEXLANSOPRAZOLEDEXLANSOPRAZOLECAPSULE, DELAYED RELEASE;ORAL60MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
24979-001DexlansoprazoledexlansoprazoleTWI PHARMACEUTICALS, INC.ANDACurrent
24979-002DexlansoprazoledexlansoprazoleTWI PHARMACEUTICALS, INC.ANDACurrent